Search company, investor...
Search

Predict your next investment

Dt&Investment company logo
Corporate Venture
FINANCE | Investment Firms & Funds
dtni.co.kr

See what CB Insights has to offer

Investments

56

Portfolio Exits

1

Partners & Customers

1

About Dt&Investment

Dt&Investment is the venture capital arm of Dt&C (KOSDAQ: 187220), a Korean testing and certification company.

Dt&Investment Headquarters Location

15F, KOTECH 305, Teheran-ro, Gangnam-gu

Seoul, 06152,

South Korea

+82 2-6009-8600

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Dt&Investment Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Dt&Investment Rank

Dt&Investment Investments

56 Investments

Dt&Investment has made 56 investments. Their latest investment was in Atlas Labs as part of their Series A on September 9, 2022.

CBI Logo

Dt&Investment Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

9/7/2022

Series A

Atlas Labs

$6.53M

Yes

3

7/29/2022

Series A

Air Klass

$7.64M

Yes

1

7/21/2022

Seed VC

Slid

$1.9M

Yes

1

5/25/2022

Seed VC

Subscribe to see more

$99M

Subscribe to see more

10

5/16/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

Date

9/7/2022

7/29/2022

7/21/2022

5/25/2022

5/16/2022

Round

Series A

Series A

Seed VC

Seed VC

Series B

Company

Atlas Labs

Air Klass

Slid

Subscribe to see more

Subscribe to see more

Amount

$6.53M

$7.64M

$1.9M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

3

1

1

10

10

Dt&Investment Portfolio Exits

1 Portfolio Exit

Dt&Investment has 1 portfolio exit. Their latest portfolio exit was Ensol Biosciences on September 21, 2018.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

9/21/2018

IPO

$99M

Public

1

Date

9/21/2018

Exit

IPO

Companies

Valuation

$99M

Acquirer

Public

Sources

1

Dt&Investment Partners & Customers

1 Partners and customers

Dt&Investment has 1 strategic partners and customers. Dt&Investment recently partnered with OurCrowd on August 8, 2018.

Date

Type

Business Partner

Country

News Snippet

Sources

8/6/2018

Partner

Israel

OurCrowd’s LABS/02 Partner with South Korea’s DTNI and Yozma

Moshe Raines , CEO of OurCrowd Labs/02 said , `` The collaboration between OurCrowd Labs/02 , DTNI and Yozma Korea , seeks to establish `` landing pads '' in Israel and South Korea , with the intention of providing startups from both countries the network to establish themselves , connect with the local startups and innovation ecosystems , and forge meaningful collaborations . ''

2

Date

8/6/2018

Type

Partner

Business Partner

Country

Israel

News Snippet

OurCrowd’s LABS/02 Partner with South Korea’s DTNI and Yozma

Moshe Raines , CEO of OurCrowd Labs/02 said , `` The collaboration between OurCrowd Labs/02 , DTNI and Yozma Korea , seeks to establish `` landing pads '' in Israel and South Korea , with the intention of providing startups from both countries the network to establish themselves , connect with the local startups and innovation ecosystems , and forge meaningful collaborations . ''

Sources

2

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.